BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7920223)

  • 1. Increased plasma M-CSF concentration in patients with adult T cell leukemia: clinical correlation.
    Yamada Y; Ohmoto Y; Murata K; Tsukasaki K; Momita S; Kamihira S; Atogami S; Sohda H; Moriuchi Y; Itoyama T
    Leuk Lymphoma; 1994 Jun; 14(1-2):151-6. PubMed ID: 7920223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of monocytosis and human monocytic colony-stimulating factor in patients with adult T-cell leukaemia/lymphoma.
    Tokioka T; Shimamoto Y; Motoyoshi K; Yamaguchi M
    Haematologia (Budap); 1994; 26(1):1-9. PubMed ID: 7959369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma M-CSF as an indicator of response to chemotherapy in adult T cell leukemia patients.
    Yamada Y; Ohmoto Y; Yamamura M; Murata K; Tsukasaki K; Jo T; Momita S; Kohno T; Hata T; Kamihira S; Tomonaga M
    Leuk Lymphoma; 1996 Aug; 22(5-6):457-61. PubMed ID: 8882959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia, and lymphoid malignancies.
    Janowska-Wieczorek A; Belch AR; Jacobs A; Bowen D; Padua RA; Paietta E; Stanley ER
    Blood; 1991 Apr; 77(8):1796-803. PubMed ID: 2015402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of high levels of plasma OX40 with acute adult T-cell leukemia.
    Tanaka Y; Takahashi Y; Tanaka R; Miyagi T; Saito M; Fukushima T
    Int J Hematol; 2019 Mar; 109(3):319-327. PubMed ID: 30652238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum deoxythymidine kinase in adult T-cell leukemia-lymphoma and its related disorders.
    Sadamori N; Ikeda S; Yamaguchi K; Mine M; Hakariya S; Kinoshita H; Hayashi K; Nakamura T; Nagataki S; Ichimaru M
    Leuk Res; 1991; 15(2-3):99-103. PubMed ID: 2016911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Soluble interleukin-2 receptor and macrophage colony-stimulating factor (M-CSF) in cerebrospinal fluid in patients with hematological malignancies: clinical significance in adult T-cell leukemia with meningeal infiltration].
    Tanaka K; Shiraishi K; Sakamoto A; Fukahori S; Jojima H; Osabe S; Mizunoe K; Masuchi K; Imamura Y; Honda J; Egami K; Natori H; Oizumi K
    Rinsho Ketsueki; 1996 Jul; 37(7):610-7. PubMed ID: 8779781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of endogenous thrombopoietin and granulocyte-colony stimulating factor in patients with acute or lymphoma type adult T-cell leukemia during multicycle chemotherapy.
    Lin XY; Hanada S; Uozumi K; Utsunomiya A; Suzuki S; Shimotakahara S; Takeuchi S; Takatsuka Y; Arima T
    Leuk Lymphoma; 2002 Feb; 43(2):343-9. PubMed ID: 11999567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage colony-stimulating factor as a tumor marker for squamous cell carcinoma of the head and neck.
    Kuropkat C; Dünne AA; Plehn S; Ossendorf M; Herz U; Renz H; Werner JA
    Tumour Biol; 2003; 24(5):236-40. PubMed ID: 15001836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of serum thymidine kinase in adult T-cell leukaemia and acute myeloid leukaemia.
    Sadamori N; Ichiba M; Mine M; Hakariya S; Hayashibara T; Itoyama T; Nakamura H; Tomonaga M; Hayashi K
    Br J Haematol; 1995 May; 90(1):100-5. PubMed ID: 7786770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6, M-CSF and IAP cytokines in ovarian cancer: simultaneous assessment of serum levels.
    Foti E; Ferrandina G; Martucci R; Romanini ME; Benedetti Panici P; Testa U; Mancuso S; Scambia G
    Oncology; 1999 Oct; 57(3):211-5. PubMed ID: 10545789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study on the serum carcinoembryonic antigen, immunosuppressive acidic protein and C-reactive protein levels in patients with adult T cell leukemia].
    Kumagai E; Ogata M; Maeda Y; Kumagai T; Okajima K; Yamaguchi K; Tanoue S
    Rinsho Byori; 1989 Jul; 37(7):769-73. PubMed ID: 2607647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of beta 2-microglobulin in serum of adult T cell leukemia.
    Sadamori N; Mine M; Hakariya S; Ichiba M; Kawachi T; Itoyama T; Nakamura H; Tomonaga M; Hayashi K
    Leukemia; 1995 Apr; 9(4):594-7. PubMed ID: 7723390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte-Colony stimulating factor and macrophage-colony stimulating factor in patients with non-small-cell lung cancer.
    Mroczko B; Szmitkowski M; Niklinski J
    Clin Chem Lab Med; 2001 May; 39(5):374-9. PubMed ID: 11434384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible mechanisms for the elevation of serum beta 2-microglobulin levels in adult T-cell leukemia.
    Tsuda H; Sawada T; Sakata KM; Takatsuki K
    Int J Hematol; 1992 Apr; 55(2):179-87. PubMed ID: 1511167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The plasma levels of granulocyte-colony stimulating factor (G-CSF) and macrophage-colony stimulating factor (M-CSF) in breast cancer patients].
    Lawicki S; Czygier M; Omyła J; Szmitkowski M
    Pol Arch Med Wewn; 2006 Aug; 116(2):749-55. PubMed ID: 17424919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of elevated levels of soluble factors in the cerebrospinal fluid in patients with adult T-cell leukemia.
    Uozumi K; Ishitsuka K; Ohno N; Nakahara K; Utsunomiya A; Hanada S; Arima T
    Leuk Lymphoma; 1995 Nov; 19(5-6):437-45. PubMed ID: 8590844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biological significance of serum tumor markers in adult T-cell leukemia.
    Sadamori N
    Leuk Lymphoma; 1996 Aug; 22(5-6):415-9. PubMed ID: 8882954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in prognostic factors between leukemia and lymphoma type of adult T-cell leukemia.
    Shimamoto Y; Ono K; Sano M; Matsuzaki M; Suga K; Sueoka E; Tokioka T; Yamaguchi M; Suzuki H; Sato H
    Cancer; 1989 Jan; 63(2):289-94. PubMed ID: 2910433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma level of macrophage-colony stimulating factor (M-CSF) in the course of breast cancer treatment].
    Lawicki S; Omyła J; Mroczko B; Szmitkowski M; Czygier M
    Pol Arch Med Wewn; 2004 Oct; 112(4):1181-7. PubMed ID: 15773430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.